BioTouch Buys Ireland’s Titan Solutions To Expand International Outreach

BioTouch, a portfolio company of Atlantic Street Capital (ASC), has acquired Ireland-based Titan Solutions for an undisclosed sum to expand its international capabilities. 

Founded in 2018, BioTouch’s services include outsourced medical supplies, kitting, and logistics services to the healthcare industry. The company’s clients include university health systems, independent laboratories, contract research organizations, and national health systems. Its technology and software enables real-time ordering and tracking of courier and specimen locations, as well as route optimization. 

Until recently, the company was known as Lab Logistics. In January 2023, it rebranded and relaunched as BioTouch to bring its subsidiary units Lab Logistics, Path Tec, Hospital Couriers, Printcraft, and The Allied Group under one name. 

Titan is a provider of logistics, kitting, and life sciences supply chain management solutions. The company offers solutions to complex supply chains to help them scale for growth. It is also a provider of diagnostic and specimen collection kits to clinics and consumers. 

Related Article: Kinnate Buys Back $24 Million Worth Of Shares From China Venture Kinnjiu

Acquisition Helps Expand BioTouch’s International Reach

The leaders of both companies have touted the acquisition as a way for BioTouch to expand in Europe and across the world, providing solutions to more than 160 countries. 

“The addition of Titan’s expertise in logistics, kitting, and life sciences supply chain management solutions, combined with our existing capabilities, will allow us to better support our customers in managing their most critical specimens and supplies, regardless of their location in the world,” said Ruth Abdulmassih, CEO of BioTouch.

“Titan’s unique position as a ‘Gateway to Europe and Rest of World’ strengthens BioTouch’s global presence,” while also emphasizing the strategic fit and seamless connectivity between both companies who have been trading partners for many years,” said Paul Collins, CEO of Titan. 

“This acquisition supports the Company’s strategy for global expansion, new temperature control product development, and material growth within the clinical trials and pharma industries,” said Andy Wilkins, Managing Partner at Atlantic Street Capital. 

Author

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless